GlassScriptPhysician profile
Christopher Isaiah Jones
NPI 1629364849
$17,327.85
in general payments reported to CMS, 2019-2025
32 companies · $4,507 in 2025
The $4,507 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,940 · 2020: $86.27 · 2021: $1,616 · 2022: $1,687 · 2023: $1,837 · 2024: $4,655 · 2025: $4,507.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,769 · Travel and Lodging: $3,627 · Consulting Fee: $2,603.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,769.46 |
| Travel and Lodging | $3,626.66 |
| Consulting Fee | $2,602.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $11,161.07 | 2019-2025 | Carto 3, Nuvision Ice Catheter, Qdot Micro Catheter |
| Boston Scientific Corporation | $2,045.17 | 2019-2025 | Farapulse, Watchman Flx, General - Therapies |
| Abbott Laboratories | $1,447.74 | 2019-2025 | Aveir, Jot Dx |
| Medtronic Vascular, INC. | $917.29 | 2019 | |
| Pfizer INC. | $275.53 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $209.24 | 2021-2025 | Eliquis, Camzyos |
| Novartis Pharmaceuticals Corporation | $163.12 | 2019-2025 | |
| Impulse Dynamics (USA) INC. | $123.39 | 2022-2025 | Optimizer |
| Medtronic, INC. | $111.62 | 2021-2024 | Reveal Linq |
| Janssen Pharmaceuticals, INC | $94.73 | 2019-2024 | Xarelto |
| Merck Sharp & Dohme LLC | $87.21 | 2023-2024 | Verquvo |
| Cvrx, INC. | $75.74 | 2022-2025 | Barostim Neo System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $73.10 | 2021-2024 | Lifevest |
| Amgen INC. | $67.97 | 2021-2024 | Repatha |
| Astrazeneca Pharmaceuticals LP | $62.90 | 2020-2024 | Farxiga |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Catheter Precision INC. | $42.80 | 2025 | |
| Cardiva Medical, INC. | $41.58 | 2022-2024 | Cardiva Vascade Mvp Vvcs 6-12f |
| Philips North America LLC | $40.58 | 2025 | Mcot, Ecc Solutions |
| Sanofi-Aventis U.S. LLC | $33.48 | 2022-2023 | |
| Novo Nordisk INC | $33.04 | 2022-2024 | Ozempic |
| Alnylam Pharmaceuticals INC. | $27.28 | 2025 | Onpattro |
| Kiniksa Pharmaceuticals, LTD. | $25.40 | 2023 | Arcalyst |
| Kiniksa Pharmaceuticals International, Plc | $24.80 | 2024 | Arcalyst |
| Esperion Therapeutics, INC. | $20.72 | 2023 | Nexletol |
| Cordis US Corp. | $20.00 | 2025 | Mynx Control Venous |
| Kestra Medical Technology Services, INC. | $16.46 | 2023 | Assure Wcd |
| Amarin Pharma, INC. | $16.26 | 2022 | |
| Circa Scientific, INC. | $15.43 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.74 | 2024 | Jardiance |
| Atricure, INC. | $13.54 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.20 | 2023 | |
| Elutia, INC. | $12.72 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Jones listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.